Category: Include on Menu
-
Interface tops Q4 profit forecasts as margins improve; shares tick higher
Interface Inc. (NASDAQ:TILE) reported fourth-quarter results on Tuesday that exceeded profit expectations, while revenue came in just shy of analyst forecasts, sending shares modestly higher in after-hours trading. The flooring manufacturer posted adjusted earnings per share of $0.49, beating the consensus estimate of $0.40. Revenue totaled $349.4 million, slightly below expectations of $349.64 million, but…
-
Avanos Medical tops Q4 earnings and revenue forecasts
Avanos Medical, Inc. (NYSE:AVNS) reported fourth-quarter results that came in ahead of Wall Street expectations on both profit and revenue, though the company’s shares were little changed in after-hours trading following the release. The medical device maker posted adjusted earnings per share of $0.29, exceeding the analyst consensus estimate of $0.25 by $0.04. Quarterly revenue…
-
Constellation Energy posts Q4 earnings miss despite strong revenue growth
Constellation Energy Corporation (NASDAQ:CEG) reported fourth-quarter results Tuesday that narrowly missed earnings expectations even as revenue came in well ahead of analyst forecasts. The company posted adjusted earnings of $2.30 per share, slightly below the consensus estimate of $2.31 per share. Revenue totaled $6.07 billion, exceeding analyst projections of $4.95 billion and rising 13% from…
-
American Tower shares slip after soft 2026 revenue outlook
American Tower Corporation (NYSE:AMT) shares declined 1.47% in pre-market trading Tuesday after the communications infrastructure provider issued 2026 revenue guidance that came in below Wall Street expectations, despite reporting stronger-than-expected fourth-quarter results. The company posted adjusted earnings per share of $1.75 for the quarter, comfortably ahead of the $1.47 consensus estimate. Revenue totaled $2.74 billion,…
-
Keurig Dr Pepper shares gain after earnings beat and upbeat outlook
Keurig Dr Pepper Inc. (NASDAQ:KDP) shares rose more than 2% in premarket trading after the beverage maker reported fourth-quarter results that topped analyst expectations and issued stronger-than-anticipated guidance for fiscal 2026. The company posted adjusted earnings per share of $0.60 for the quarter, exceeding forecasts by $0.01, while revenue reached $4.5 billion, ahead of the…
-
AMD shares jump on expanded AI infrastructure partnership with Meta
Advanced Micro Devices (NASDAQ:AMD) shares climbed 9% on Tuesday after earlier surging as much as 14% following news of an expanded multi-year collaboration with Meta (NASDAQ:META) focused on supplying graphics processing units for artificial intelligence infrastructure. Under the agreement, AMD will provide Instinct GPUs as part of a large-scale deployment expected to reach up to…
-
X3 Holdings enters AI healthcare market through smartwatch commercialization partnership
X3 Holdings Co., Ltd. (NASDAQ:XTKG) announced it has signed a strategic agreement with an artificial intelligence healthcare technology company to support the global rollout of an AI-powered healthcare smartwatch, marking the company’s expansion into the digital health sector. Under the partnership, X3 Holdings will assist with international commercialization and operational deployment of the wearable device,…
-
Ten-League International forecasts strong FY2025 growth on Singapore infrastructure momentum
Ten-League International Holdings Limited (NASDAQ:TLIH), a Singapore-based provider of turnkey project solutions for the port, construction, civil engineering and underground foundation sectors, issued upbeat financial guidance for fiscal year 2025, citing robust demand tied to major infrastructure developments in Singapore. The company, which supplies heavy equipment, spare parts and engineering consultancy services, said it expects…
-
Nexalin launches pivotal HALO Clarity trial to support FDA submission for insomnia treatment
Nexalin Technology, Inc. (NASDAQ:NXL) has initiated its pivotal HALO Clarity clinical trial, a key step toward a planned de novo submission to the U.S. Food and Drug Administration seeking clearance for its insomnia treatment technology. The study will evaluate the company’s non-drug Deep Intracranial Frequency Stimulation (DIFS) platform, which Nexalin is positioning as a potential…
-
Klotho Neurosciences advances epigenetic diagnostics with development of AI-driven “Klotho Clock”
Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced the launch of a new genomics diagnostics initiative centered on two epigenetics-based tests designed to support its clinical trials and expand applications in longevity research and biological aging assessment. The company said the tools aim to improve understanding of the relationship between chronological age and biological age while enabling more…